A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn
a study on Erythroblastosis, Fetal
Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN) Erythroblastosis, Fetal Hemolytic disease of the fetus and newborn (HDFN) M281 Pregnant Women Hemolysis No intervention Pregnant women and their offspring from current pregnancy
- accepting new patients
- Start Date
- Completion Date
- Momenta Pharmaceuticals, Inc.
- To learn how to participate in this trial please click here.
- Study Type
- Last Updated